Literature DB >> 2036300

Control of brain endothelial permeability.

N J Abbott1, P A Revest.   

Abstract

The endothelium of the brain microvasculature is much tighter than that elsewhere in the body. Although brain endothelium appears to possess the same routes for transendothelial transfer as other endothelia, the rarity of some routes leads to an extremely low overall permeability. Cells associated with brain endothelium, particularly astrocytic glial cells, appear to be involved in induction of the low permeability state. Although relatively unaffected by hypoxia and changes in plasma ion concentration, brain endothelial permeability is increased by stretch and shrinkage of endothelial cells, and by inflammatory mediators. Recent evidence suggests that many mediators of increased transendothelial permeability act by raising intracellular free calcium, and causing a contractile event that pulls apart the tight junctions; this also appears to apply to brain endothelium. Comparison of the brain endothelium with the perineurium of peripheral nerve, part of the blood-nerve barrier, suggests that the modulation of brain endothelial permeability seen in pathological situations may give some physiological advantage.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2036300

Source DB:  PubMed          Journal:  Cerebrovasc Brain Metab Rev        ISSN: 1040-8827


  23 in total

Review 1.  Osmotic opening of the blood-brain barrier: principles, mechanism, and therapeutic applications.

Authors:  S I Rapoport
Journal:  Cell Mol Neurobiol       Date:  2000-04       Impact factor: 5.046

Review 2.  Considerations in the use of cerebrospinal fluid pharmacokinetics to predict brain target concentrations in the clinical setting: implications of the barriers between blood and brain.

Authors:  Elizabeth C M de Lange; Meindert Danhof
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

Review 3.  Therapeutic strategies to improve drug delivery across the blood-brain barrier.

Authors:  Tej D Azad; James Pan; Ian D Connolly; Austin Remington; Christy M Wilson; Gerald A Grant
Journal:  Neurosurg Focus       Date:  2015-03       Impact factor: 4.047

Review 4.  Dynamics of CNS barriers: evolution, differentiation, and modulation.

Authors:  N Joan Abbott
Journal:  Cell Mol Neurobiol       Date:  2005-02       Impact factor: 5.046

5.  Dietary blueberry supplementation affects growth but not vascularization of neural transplants.

Authors:  Lauren M Willis; Brent J Small; Paula C Bickford; Claudia D Umphlet; Alfred B Moore; Ann-Charlotte E Granholm
Journal:  J Cereb Blood Flow Metab       Date:  2008-02-20       Impact factor: 6.200

Review 6.  The astrocyte odyssey.

Authors:  Doris D Wang; Angélique Bordey
Journal:  Prog Neurobiol       Date:  2008-10-01       Impact factor: 11.685

Review 7.  Past, present and future of A(2A) adenosine receptor antagonists in the therapy of Parkinson's disease.

Authors:  Marie Therese Armentero; Annalisa Pinna; Sergi Ferré; José Luis Lanciego; Christa E Müller; Rafael Franco
Journal:  Pharmacol Ther       Date:  2011-07-23       Impact factor: 12.310

Review 8.  Astrocyte-endothelial interactions and blood-brain barrier permeability.

Authors:  N Joan Abbott
Journal:  J Anat       Date:  2002-06       Impact factor: 2.610

Review 9.  Blood-brain barrier breakdown in septic encephalopathy and brain tumours.

Authors:  D C Davies
Journal:  J Anat       Date:  2002-06       Impact factor: 2.610

10.  Stimulation of phospholipase C in cultured microvascular endothelial cells from human frontal lobe by histamine, endothelin and purinoceptor agonists.

Authors:  J R Purkiss; D West; L C Wilkes; C Scott; P Yarrow; G F Wilkinson; M R Boarder
Journal:  Br J Pharmacol       Date:  1994-04       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.